reglab/housing_qa huggingface dataset:
IN Code § 25-26-13.5-10 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-10. Electronic Record Keeping System

Sec. 10. A remote dispensing facility and the supervising pharmacy must use a common electronic record keeping system that is capable of the following:(1) Allowing the electronic records to be available to and accessible from both the supervising pharmacy and the remote dispensing facility.(2) Distinguishing between prescriptions filled at the supervising pharmacy and those filled at the remote dispensing facility.(3) Allowing pharmacies to generate labels at the supervising pharmacy.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-11 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-11. Video and Audio Communication System; Retention of Recordings; Requirements; Nonoperating System

Sec. 11. (a) A supervising pharmacy of a remote dispensing facility must maintain a video and audio communication system that provides for effective communication between the supervising pharmacy, the remote dispensing facility, and any consumers. The system must do the following:(1) Provide an adequate number of views of the entire remote dispensing facility.(2) Facilitate adequate pharmacist supervision.(3) Allow an appropriate exchange of visual, verbal, and written communications for patient counseling and other matters concerning the lawful transaction of business.(b) The remote dispensing facility must retain a recording of facility surveillance, excluding patient communications, for at least thirty (30) days.(c) A qualifying pharmacist is adequately supervising through the use of video surveillance by maintaining constant visual supervision and auditory communication with the remote dispensing facility and by maintaining full supervisory control of the automated system, if applicable. The auditory communication must be available, as needed, with the remote dispensing facility and the qualifying pharmacist.(d) A video monitor that is being used to properly identify and communicate with consumers must meet the following requirements:(1) Provide both the supervising pharmacy and the remote dispensing facility with direct visual contact between the pharmacist and the consumer.(2) Be secure and compliant with the federal Health Insurance Portability and Accountability Act (HIPAA).(e) If any component of the communication system is not in operating order, the remote dispensing facility shall remain closed until the communication system is fully operational, unless a pharmacist is located at the remote dispensing facility.As added by P.L.202-2017, SEC.12. Amended by P.L.246-2019, SEC.17; P.L.207-2021, SEC.40.
IN Code § 25-26-13.5-12 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-12. Maintenance of Controlled Substance Dispensing Records

Sec. 12. The remote dispensing facility must maintain records of any dispensing of a controlled substance at the remote dispensing facility, unless the remote dispensing facility has received approval to centrally store the records in compliance with federal law.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-13 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-13. Effect of Supervising Pharmacy Being Closed

Sec. 13. A remote dispensing facility may not be open and employees may not have access to the facility when the supervising pharmacy is closed, unless a pharmacist is on duty at the remote dispensing facility.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-14 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-14. Security; Review; Storage Area

Sec. 14. (a) A remote dispensing facility shall have adequate security. The security must do the following:(1) Record the entrance and exit of individuals to the facility.(2) Use alarms or other comparable monitoring systems that protect the equipment, records, drug supply, devices, and other items from unauthorized access, acquisition, or use.(3) Use at least two (2) factoring credentials for employee entry to the remote dispensing facility, using two (2) of the following:(A) A knowledge factor, including a password.(B) Biometrics.(C) An inanimate object.(b) The qualifying pharmacist shall periodically review the record of entries into the remote dispensing facility.(c) The prescription storage area may remain open while a pharmacist or pharmacy technician is on duty.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-15 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-15. Dispensing Controlled Substances; Automated Dispensing Machines; Deliveries; Storage

Sec. 15. (a) A controlled substance may not be dispensed at the remote dispensing facility unless:(1) the facility maintains a perpetual inventory of controlled substances; and(2) the supervising pharmacist checks the Indiana scheduled prescription electronic collection and tracking program established by IC 25-1-13-4 or as directed by the board before:(A) verification of the finished controlled substance prescription; and(B) counseling the patient.(b) Drugs may be transported to a remote dispensing facility that uses an automated dispensing machine only in a sealed container with a list identifying each drug, drug strength, and quantity included in the container.(c) A delivery of drugs may be accepted at the remote dispensing facility only if a pharmacist or a licensed pharmacy technician is present to accept delivery and verify and sign for the receipt of the drugs, unless the drugs are placed in a secured delivery area that complies with federal and state law.(d) If the delivery is received by a pharmacy technician, a pharmacist at the supervising pharmacy shall ensure through the use of the electronic audio and video communication system or bar code technology that the pharmacy technician has accurately restocked the drugs.(e) A remote dispensing facility must store drugs in a manner that:(1) complies with federal and state law;(2) protects the identity, safety, security, and integrity of the drug; and(3) limits access to:(A) a pharmacist employed by the supervising pharmacy; and(B) a pharmacy technician who has written authorization of the qualifying pharmacist to access the facility.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-16 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-16. Pharmacy Technicians; Prescription Records; Verification System

Sec. 16. (a) If a pharmacy technician at a remote dispensing facility enters prescription drug information into an automated pharmacy system, a pharmacist at the supervising pharmacy shall, before approving the prescription, verify the information entered against a faxed, electronic, or video image of the original prescription.(b) The pharmacy technician may do any of the following:(1) Transmit the prescription drug order to the pharmacist by scanning the order into the electronic record keeping system as long as the image is legible and does not obscure the prescription drug information.(2) Make the original prescription available to the pharmacist by placing the prescription in view of the video communication system. The pharmacist shall also verify the accuracy of the drug dispensed and check the prescription drug label for accuracy.(3) Fax the prescription to the pharmacist, unless prohibited by law for controlled substances.(c) Both the initials or other unique identifier of the pharmacy technician and the pharmacist involved in the dispensing must appear on the prescription record.(d) The remote dispensing facility must use an electronic verification system that confirms the drug stock selected to fill the prescription is the same as the drug indicated on the prescription label.(e) The pharmacist shall verify each prescription before it is dispensed.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-17 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-17. Suspension of Registration

Sec. 17. The board may suspend a registration under this chapter if the facility poses a danger to the public.As added by P.L.202-2017, SEC.12.
IN Code § 25-26-13.5-18 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 13.5. Remote Dispensing Facilities|25-26-13.5-18. Rules

Sec. 18. (a) The board may adopt rules under IC 4-22-2 necessary to implement this chapter.(b) The Indiana board of pharmacy shall adopt rules under IC 4-22-2, including emergency rules in the manner provided under IC 4-22-2-37.1, to implement sections 6.5 and 6.7 of this chapter with respect to telepharmacy. This subsection expires July 1, 2020.As added by P.L.202-2017, SEC.12. Amended by P.L.209-2018, SEC.11; P.L.246-2019, SEC.18.
IN Code § 25-26-14-1 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-1. Application of Chapter

Sec. 1. (a) This chapter applies to any individual, partnership, limited liability company, corporation, or business firm:(1) located in or outside Indiana; and(2) engaging in the wholesale distribution of legend drugs in Indiana.(b) Except as required by federal law or regulation, the requirements of this chapter do not apply to a manufacturer that is approved by the federal Food and Drug Administration. However, the board may adopt rules concerning manufacturers that the board considers appropriate and necessary.(c) The requirements of this chapter do not apply to a medical gas manufacturer or distributor that only manufactures or distributes medical gases.As added by P.L.182-1991, SEC.3. Amended by P.L.8-1993, SEC.394; P.L.212-2005, SEC.23; P.L.98-2006, SEC.12.
IN Code § 25-26-14-1.5 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-1.5. "Adulterated"

Sec. 1.5. As used in this chapter, "adulterated" refers to a legend drug that:(1) consists in whole or in part of a filthy, putrid, or decomposed substance;(2) has been produced, prepared, packed, or held under unsanitary conditions and may have been contaminated or rendered injurious to health;(3) has been subjected to conditions in the manufacture, processing, packing, or holding of the legend drug that do not conform to current standards of manufacturing to ensure that the legend drug is safe for use and possesses the identity, strength, quality, and purity characteristics that the legend drug is represented to possess;(4) is contained in a container composed of a poisonous or deleterious substance that may render the legend drug injurious to health;(5) bears or contains, for purposes of coloring only, a color additive that is unsafe;(6) is of a different strength, quality, or purity from the official compendium standard for the legend drug; or(7) does not meet the considerations of the federal Food, Drug, and Cosmetic Act.As added by P.L.212-2005, SEC.24.
IN Code § 25-26-14-1.7 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-1.7. "Authenticate"

Sec. 1.7. As used in this chapter, "authenticate" means to affirmatively verify before distribution occurs that each transaction that is listed on:(1) the pedigree of a legend drug; and(2) other accompanying documentation for a legend drug;has occurred.As added by P.L.212-2005, SEC.25.
IN Code § 25-26-14-1.8 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-1.8. "Authorized Distributor"

Sec. 1.8. As used in this chapter, "authorized distributor" means a wholesale drug distributor with which a manufacturer has established an ongoing relationship to distribute the manufacturer's products. For purposes of this section, an ongoing relationship exists between a wholesale drug distributor, including any affiliated group (as defined in Section 1504 of the Internal Revenue Code) of which the wholesale distributor is a member, and a manufacturer if the wholesale drug distributor:(1) has a written agreement currently in effect with the manufacturer evidencing an ongoing relationship;(2) is listed on the manufacturer's current monthly updated list of authorized distributors; or(3) has a verifiable account with the manufacturer and a minimal transaction or volume requirement limit of:(A) five thousand (5,000) units per company in the previous twelve (12) months; or(B) twelve (12) purchases at the manufacturer's minimum purchasing requirement per invoice in the previous twelve (12) months.As added by P.L.212-2005, SEC.26.
IN Code § 25-26-14-2 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-2. "Blood"

Sec. 2. As used in this chapter, "blood" means whole blood collected from a single donor and processed either for transfusion or further manufacturing.As added by P.L.182-1991, SEC.3.
IN Code § 25-26-14-3 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-3. "Blood Component"

Sec. 3. As used in this chapter, "blood component" means that part of blood separated by physical or mechanical means.As added by P.L.182-1991, SEC.3.
IN Code § 25-26-14-3.7 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-3.7. "Chain Drug Warehouse"

Sec. 3.7. As used in this chapter, "chain drug warehouse" means a permanent physical location for drugs or devices, or both, that:(1) is licensed as a wholesale distributor;(2) acts as a central warehouse; and(3) primarily performs intracompany sales and transfers of legend drugs or devices to members of the same affiliated group that is under common ownership and control.As added by P.L.98-2006, SEC.13.
IN Code § 25-26-14-4 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4. "Board"

Sec. 4. As used in this chapter, "board" refers to the Indiana board of pharmacy established under IC 25-26-13-3.As added by P.L.182-1991, SEC.3.
IN Code § 25-26-14-4.1 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.1. "Co-Licensed Products"

Sec. 4.1. As used in this chapter, "co-licensed products" means pharmaceutical products:(1) that have been approved by the federal Food and Drug Administration; and(2) concerning which two (2) or more parties have the right to engage in a business activity or occupation concerning the pharmaceutical products.As added by P.L.212-2005, SEC.27.
IN Code § 25-26-14-4.2 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.2. "Compendium"

Sec. 4.2. As used in this chapter, "compendium" refers to:(1) the United States Pharmacopoeia;(2) the Homeopathic Pharmacopoeia of the United States;(3) the National Formulary;(4) a drug approved by the federal Food and Drug Administration; or(5) a supplement to a document specified in subdivision (1), (2), or (3).As added by P.L.212-2005, SEC.28.
IN Code § 25-26-14-4.3 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.3. "Contraband"

Sec. 4.3. As used in this chapter, "contraband" refers to a legend drug:(1) that is counterfeit;(2) that is stolen;(3) that is misbranded;(4) that is obtained by fraud;(5) that is purchased by a nonprofit institution for the nonprofit institution's own use and placed in commerce in violation of the own use agreement for the legend drug;(6) for which a required pedigree does not exist; or(7) for which a pedigree in existence:(A) has been forged, counterfeited, or falsely created; or(B) contains any altered, false, or misrepresented information.As added by P.L.212-2005, SEC.29.
IN Code § 25-26-14-4.4 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.4. "Counterfeit"

Sec. 4.4. As used in this chapter, "counterfeit" refers to a legend drug, or the container, seal, or labeling of a legend drug, that, without authorization, bears the trademark, trade name, or other identifying mark or imprint of a manufacturer, processor, packer, or distributor other than the person that manufactured, processed, packed, or distributed the legend drug.As added by P.L.212-2005, SEC.30.
IN Code § 25-26-14-4.5 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.5. "Deliver"

Sec. 4.5. As used in this chapter, "deliver" means the actual, constructive, or attempted transfer of a legend drug from one (1) person to another.As added by P.L.212-2005, SEC.31.
IN Code § 25-26-14-4.6 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.6. "Designated Representative"

Sec. 4.6. As used in this chapter, "designated representative" means an individual who:(1) is designated by a wholesale drug distributor;(2) serves as the wholesale drug distributor's responsible individual with the board; and(3) is actively involved in and aware of the actual daily operation of the wholesale drug distributor.As added by P.L.212-2005, SEC.32.
IN Code § 25-26-14-4.7 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-4.7. "Distribute"

Sec. 4.7. As used in this chapter, "distribute" means to sell, offer to sell, deliver, offer to deliver, broker, give away, or transfer a legend drug, whether by passage of title or physical movement, or both. The term does not include the following:(1) Dispensing or administering a legend drug.(2) Delivering or offering to deliver a legend drug by a common carrier in the usual course of business as a common carrier.(3) The provision of a legend drug sample to a patient by a:(A) practitioner;(B) health care professional acting at the direction and under the supervision of a practitioner; or(C) hospital's or other health care entity's pharmacy that received the drug sample in accordance with this chapter and other applicable law to administer or dispense and that is acting at the direction of a practitioner;licensed to prescribe the legend drug.As added by P.L.212-2005, SEC.33.
IN Code § 25-26-14-5 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-5. "Drug Sample"

Sec. 5. As used in this chapter, "drug sample" means a unit of a legend drug that is not intended to be sold and is intended to promote the sale of the drug.As added by P.L.182-1991, SEC.3.
IN Code § 25-26-14-6 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-6. "Health Care Entity"

Sec. 6. As used in this chapter, "health care entity" means any organization or business that provides diagnostic, medical, surgical, dental treatment, or rehabilitative care. The term does not include a pharmacy or wholesale drug distributor.As added by P.L.182-1991, SEC.3. Amended by P.L.212-2005, SEC.34.
IN Code § 25-26-14-6.5 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-6.5. "Label"

Sec. 6.5. As used in this chapter, "label" means a display of written, printed, or graphic matter on the immediate container of a legend drug.As added by P.L.212-2005, SEC.35.
IN Code § 25-26-14-6.6 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-6.6. "Labeling"

Sec. 6.6. As used in this chapter, "labeling" means labels and other written, printed, or graphic matter:(1) on a legend drug or a legend drug's container or wrapper; or(2) accompanying a legend drug.As added by P.L.212-2005, SEC.36.
IN Code § 25-26-14-7 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-7. "Legend Drug"

Sec. 7. As used in this chapter, "legend drug" has the meaning set forth in IC 16-18-2-199. The term includes any human drug required by federal law or regulation to be dispensed only by a prescription, including finished dosage forms and active ingredients subject to 21 U.S.C. 811 through 812. The term does not include a device or a device component, part, or accessory.As added by P.L.182-1991, SEC.3. Amended by P.L.2-1993, SEC.147; P.L.212-2005, SEC.37.
IN Code § 25-26-14-8 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-8. "Manufacturer"

Sec. 8. As used in this chapter, "manufacturer" means a person who is engaged in manufacturing, preparing, propagating, compounding, processing, packaging, repackaging, or labeling of a legend drug.As added by P.L.182-1991, SEC.3.
IN Code § 25-26-14-8.3 (2021)
2021 Indiana Code|Title 25. Professions and Occupations|Article 26. Pharmacists, Pharmacies, Drug Stores|Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers|25-26-14-8.3. "Misbranded"

Sec. 8.3. As used in this chapter, "misbranded" means that a legend drug's label:(1) is false or misleading;(2) does not bear the name and address of the manufacturer, packer, or distributor or does not contain an accurate statement of the quantities of active ingredients of the legend drug;(3) does not show an accurate monograph for the legend drug; or(4) does not comply with any other requirements of the federal Food, Drug, and Cosmetic Act.As added by P.L.212-2005, SEC.38.